Abstract
Primary progressive aphasia (PPA) is an insidiously progressive clinical syndrome that includes at its core an impairment in language. From a clinical perspective, there are a variety of diagnostic challenges; international consensus has only recently been reached on the nomenclature for specific clinical subtypes. There are at present no established treatments, and efforts to develop treatments have been hampered by the lack of standardized methods to monitor progression of the illness. This is further complicated by the multiplicity of underlying neuropathologies. Although measures developed from work with stroke aphasia and from work with disorders such as Alzheimer’s disease and frontotemporal dementia have provided a valuable foundation for monitoring progression, PPA presents unique challenges to clinicians aiming to quantify impairments for the purposes of full characterization and monitoring, and ultimately with the goal of designing clinical trials of interventions to make a meaningful difference in patients’ lives. In this review, I will summarize the main points made in my presentation at the 2010 International Conference on Frontotemporal Dementia, expand from there to summarize our current approach to monitoring progression of PPA, and finally will outline some ideas about goals for the development of better tools for this purpose.
Similar content being viewed by others
References
Alladi S, Xuereb J, Bak T, Nestor P, Knibb J, Patterson K, Hodges JR (2007) Focal cortical presentations of Alzheimer’s disease. Brain 130:2636–2645
DeKosky ST, Marek K (2003) Looking backward to move forward: early detection of neurodegenerative disorders. Science 302:830–834
Dickerson BC, Sperling RA (2005) Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer’s disease. NeuroRx 2:348–360
Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Morris JC, Fischl B, Buckner RL (2009) The cortical signature of Alzheimer’s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 19:497–510
Goodglass H, Kaplan E, Barresi B (2001) Boston diagnostic aphasia examination, third edition (BDAE-3). Pro-Ed, Austin
Gordon E, Rohrer JD, Kim LG, Omar R, Rossor MN, Fox NC, Warren JD (2010) Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study. Neurology 74:666–673
Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ, Johnson JK, Weiner MW, Miller BL (2004) Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 55:335–346
Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam M, Grossman M (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006–1014
Grossman M (2010) Primary progressive aphasia: clinicopathological correlations. Nat Rev Neurol 6:88–97
Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K (2010) Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov 9:560–574
Henry ML, Beeson PM, Rapcsak SZ (2008) Treatment for lexical retrieval in progressive aphasia. Aphasiology 22:826–838
Hodges JR (2001) Frontotemporal dementia (Pick’s disease): clinical features and assessment. Neurology 56:S6–S10
Hodges JR, Mitchell J, Dawson K, Spillantini MG, Xuereb JH, McMonagle P, Nestor PJ, Patterson K (2010) Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. Brain 133:300–306
Johnson N, Barion A, Rademaker A, Rehkemper G, Weintraub S (2004) The activities of daily living questionnaire: a validation study in patients with dementia. Alzheimer Dis Assoc Disord 18:223–230
Johnson NA, Rademaker A, Weintraub S, Gitelman D, Wienecke C, Mesulam M (2010) Pilot trial of memantine in primary progressive aphasia. Alzheimer Dis Assoc Disord 24:308
Josephs KA (2008) Frontotemporal dementia and related disorders: deciphering the enigma. Ann Neurol 64:4–14
Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, Parisi JE, Hauser MF, Witte RJ, Boeve BF, Knopman DS, Dickson DW, Jack CR Jr, Petersen RC (2006) Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129:1385–1398
Kertesz A (1982) Western aphasia battery. Grune and Stratton, New York
Kertesz A, Hudson L, Mackenzie IR, Munoz DG (1994) The pathology and nosology of primary progressive aphasia. Neurology 44:2065–2072
Kertesz A, Morlog D, Light M, Blair M, Davidson W, Jesso S, Brashear R (2008) Galantamine in frontotemporal dementia and primary progressive aphasia. Dement Geriatr Cogn Disord 25:178–185
Knopman DS, Kramer JH, Boeve BF, Caselli RJ, Graff-Radford NR, Mendez MF, Miller BL, Mercaldo N (2008) Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain 131:2957–2968
Knopman DS, Jack CR Jr, Kramer JH, Boeve BF, Caselli RJ, Graff-Radford NR, Mendez MF, Miller BL, Mercaldo ND (2009) Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year. Neurology 72:1843–1849
Le Rhun E, Richard F, Pasquier F (2005) Natural history of primary progressive aphasia. Neurology 65:887–891
Leyton CE, Hornberger M, Mioshi E, Hodges JR (2010) Application of Addenbrooke’s cognitive examination to diagnosis and monitoring of progressive primary aphasia. Dement Geriatr Cogn Disord 29:504–509
McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ (2001) Clinical and pathological diagnosis of frontotemporal dementia: report of the work group on frontotemporal dementia and Pick’s disease. Arch Neurol 58:1803–1809
Mesulam MM (1982) Slowly progressive aphasia without generalized dementia. Ann Neurol 11:592–598
Mesulam M, Weintraub S (2008) Primary progressive aphasia and kindred disorders. Handb Clin Neurol 89:573–587
Mesulam M, Wicklund A, Johnson N, Rogalski E, Leger GC, Rademaker A, Weintraub S, Bigio EH (2008) Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 63:709–719
Mesulam M, Wieneke C, Rogalski E, Cobia D, Thompson C, Weintraub S (2009) Quantitative template for subtyping primary progressive aphasia. Arch Neurol 66:1545–1551
Mioshi E, Hodges JR (2009) Rate of change of functional abilities in frontotemporal dementia. Dement Geriatr Cogn Disord 28:419–426
Mioshi E, Kipps CM, Dawson K, Mitchell J, Graham A, Hodges JR (2007) Activities of daily living in frontotemporal dementia and Alzheimer disease. Neurology 68:2077–2084
Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43:2412–2414
Mosconi L, Brys M, Glodzik-Sobanska L, De Santi S, Rusinek H, de Leon MJ (2007) Early detection of Alzheimer’s disease using neuroimaging. Exp Gerontol 42:129–138
Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546–1554
Ogar J, Slama H, Dronkers N, Amici S, Gorno-Tempini ML (2005) Apraxia of speech: an overview. Neurocase 11:427–432
Okamura N, Suemoto T, Furumoto S, Suzuki M, Shimadzu H, Akatsu H, Yamamoto T, Fujiwara H, Nemoto M, Maruyama M, Arai H, Yanai K, Sawada T, Kudo Y (2005) Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer’s disease. J Neurosci 25:10857–10862
Peelle JE, Troiani V, Gee J, Moore P, McMillan C, Vesely L, Grossman M (2008) Sentence comprehension and voxel-based morphometry in progressive nonfluent aphasia, semantic dementia, and nonaphasic frontotemporal dementia. J Neurolinguistics 21:418–432
Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, O’Neil JP, Lal RA, Dronkers NF, Miller BL, Gorno-Tempini ML (2008) Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 64:388–401
Reed DA, Johnson NA, Thompson C, Weintraub S, Mesulam MM (2004) A clinical trial of bromocriptine for treatment of primary progressive aphasia. Ann Neurol 56:750
Rogalski EJ, Mesulam MM (2009) Clinical trajectories and biological features of primary progressive aphasia (PPA). Curr Alzheimer Res 6:331–336
Rohrer JD, Ridgway GR, Crutch SJ, Hailstone J, Goll JC, Clarkson MJ, Mead S, Beck J, Mummery C, Ourselin S, Warrington EK, Rossor MN, Warren JD (2009a) Progressive logopenic/phonological aphasia: erosion of the language network. Neuroimage 49:984–993
Rohrer JD, Warren JD, Modat M, Ridgway GR, Douiri A, Rossor MN, Ourselin S, Fox NC (2009b) Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology 72:1562–1569
Sapolsky D, Bakkour A, Negreira A, Nalipinski P, Weintraub S, Mesulam MM, Caplan D, Dickerson BC (2010) Cortical neuroanatomic correlates of symptom severity in primary progressive aphasia. Neurology 75:358–366
Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ (2009) Alzheimer’s disease neuroimaging I. Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects. Ann Neurol 65:403–413
Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, Thompson PM, Huang SC, Satyamurthy N, Phelps ME, Barrio JR (2006) PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 355:2652–2663
Weintraub S, Mesulam MM, Wieneke C, Rademaker A, Rogalski EJ, Thompson CK (2009) The northwestern anagram test: measuring sentence production in primary progressive aphasia. Am J Alzheimers Dis Other Demen 24:408–416
Wicklund AH, Johnson N, Rademaker A, Weitner BB, Weintraub S (2007) Profiles of decline in activities of daily living in non-Alzheimer dementia. Alzheimer Dis Assoc Disord 21:8–13
Financial Disclosure/Acknowledgments
This work was supported by grants from the NIA R01-AG29411, R21-AG29840, P50-AG005134, and the Alzheimer’s Association. We express special appreciation to the participants in our program and their families for their valuable contributions. The author thanks Daisy Sapolsky, MS, CCC-SLP for her dedicated collaborative partnership in these efforts. The author reports no disclosures.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dickerson, B.C. Quantitating Severity and Progression in Primary Progressive Aphasia. J Mol Neurosci 45, 618–628 (2011). https://doi.org/10.1007/s12031-011-9534-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-011-9534-2